This technical note reports the current status of work being done at the U.S. Army Engineer Research and Development Center (ERDC) to develop cDNA array-based assays that map gene expression from contaminant exposures. Results substantiate that distinct gene expression profiles exist for major contaminant classes such as PAHs, PCBs, and PCDD/Fs. Results also indicate that identification of these contaminant mixtures in environmental media is possible by examining their effects on gene expression in mammalian cells.
In this investigation a cultured cell line (human hepatoma, HepG2) was exposed to known compounds/mixtures in order to develop genetic-response fingerprints for common contaminant classes; future work will involve testing extracts of environmental samples (sediments, tissues) to relate the responses seen with model chemicals to those of complex mixtures present in field samples. Gene responses were monitored with Clontech's commercially available Atlas™ Human Toxicology 1.2 cDNA array, which includes 1176 genes known to be involved in toxicological responses, e.g., genes linked to DNA synthesis/repair, stress proteins, and tumor suppression or induction. Results substantiate that distinct gene expression profiles exist for major contaminant classes such as PAHs, PCBs, and 2, 3,7,8 -tetrachlorodibenzo[p] dioxin (2, 3, 7, 8 TCDD) .
METHODS AND MATERIALS:
Cell Exposures and cDNA Array Assay. HepG2 cells were exposed to the model chemical contaminants, and the cellular mRNA was harvested. For each exposure, four replicate T-150 culture flasks were seeded with 5 x 10 6 HepG2 cells, allowed to grow to 80-percent confluency, and then dosed. Table 1 lists nominal dose levels and concentrations of the individual chemicals in the mixtures. Contaminants were added in 150-uL aliquots of isooctane to the 15-mL minimum essential medium (MEM) media in each flask; a solvent control (150 uL of iso-octane) was dosed at the same time. Cells were exposed for 16 hr to either pure 2, 3,7,8-tetrachlorodibenzo[p] dioxin (TCDD, Ultra Scientific #RPE-029S), a PAH mixture (Ultra Scientific #PM-810), or a PCB mixture (Aroclor 1254, EPA-Research Triangle Park #5705), each at three dose levels. All dose levels for all compounds in this investigation were below acutely toxic doses, as monitored by trypan blue viability stain. Cells were exposed to the test chemicals for 16 hr, washed with 1x phosphate buffered saline (PBS), counted, and centrifuged. The cell pellets were stored in 5 volumes of RNAlater (Ambion #7021) at -20 o C for RNA isolation. The mRNA was isolated using Clontech's Atlas™ Pure Total RNA Labeling Kit with modifications; details of the RNA isolation procedure are provided in Appendix A.
Following isolation, the mRNA was converted into cDNA ( Figure 1 ) using reverse transcription. Procedures for Clontech's SpotLight™ Random Primer Labeling Kit were followed (http://www. bdbiosciences.com/clontech/techinfo/manuals/PDF/PT3516-1.pdf). The only modification was the use of the CDP-Star primers provided with the arrays. Briefly, the extracted mRNA was placed in a tube with "primers," or short DNA sequences (oligonucleotides), which bind to complementary sequences on the mRNA targets; primers are optimized for the genes targeted on the array, and used as provided by the manufacturer with the arrays. An enzyme then binds to the primer/mRNA complex and makes a complementary DNA copy of the mRNA sequence (cDNA). The cDNA is also labeled during this step with biotin, which allows chemiluminescent visualization after it is bound to the array.
The resulting cDNA was bound (hybridized) to the array in a complementary sequence-specific manner during overnight exposure. Gene responses were quantified by the amount of biotinlabeled cDNA bound at each spot on the array as detected via a light-producing reaction in which Streptavidin-bound horseradish peroxidase binds specifically to the biotin label incorporated in the cDNA. Methodologies for the Clontech Spotlight™ Chemiluminescent Hybridization and Detection Kit were followed without modification for both hybridization and detection. The light output was captured using a digital imaging analysis system (AlphaInnotech's Fluorchem 8000). Representative results from control and exposed arrays are shown in Figure 2 .
Data analysis. The digital images of the arrays were analyzed with AtlasImage 2.0 (Clontech), which provides local background and spot densitometry data for all genes. Background corrected data were summed for all genes in the array, and the data were then normalized to the total intensity of all spots to allow comparisons between arrays, since the amount of cDNA applied to each array may differ. The data were then analyzed using a semi-parametric technique that uses local regression to estimate the normalized expression levels as well as the expression level-dependent error variance (Kepler et al. 2002 ). The technique is based on assumptions that the large majority of genes will not have their relative expression levels changed from one treatment group to the next, and that departures of the response from linearity are small and vary slowly. For each compound, gene responses at each dose were compared to controls independently. The statistical data and gene expression data were then examined to determine which genes were responding consistently across all doses. In order to determine whether gene responses were characteristic for the different compounds, all genes that were expressed at a significantly different level than their corresponding control were combined for a given compound regardless of dose, and the resultant list of genes compared between the compounds. The Vin diagram in Figure 3 displays the overlap in responding genes between the treatments; the box in each circle defines the compound the circle represents, with the total number of responding genes in parentheses; overlapping sectors represent genes in common for the compounds, with the number enclosed in the overlapping sectors representing the number of genes in common. Some overlap in differentially expressed genes was observed, which was expected since selected PCBs and PAHs are known to interact with the same receptor system responsible for toxicity of TCDD. However, the bulk of the genes were unique to each treatment, with only two genes responding to all three treatments; only 32 of the combined 320 genes were differentially expressed by more than one compound, supporting the application of this technique for identifying contaminants and/or contaminant classes. However, for application as a screening technique for environmental samples it is also desirable that the genes respond in a consistent manner across a wide range of doses. This requirement reduces the number of selected genes, as some genes that respond at lower doses may not respond at higher doses, and vice versa. The wide dose range over which the response was required to be consistent explains the lack of expected response of some genes, such as cyp1A1 for TCDD. Frueh et al. (2001) used RT-PCR to determine the concentration-dependent gene response to 2,3,7,8-TCDD in HepG2 cells, and found that many of the genes are not induced until concentrations reach at least 100 pM TCDD; the doses in this study were equivalent to 311, 78, and 23 pM TCDD. The gene was thus eliminated, as the selection criteria depended on a consistent response over the entire dose range, and cyp1A1 was only induced in two of the three tested doses. at four doses ranging from 0.1 to 100 mg/kg, and tetrachloroethylene (TCE) at three doses ranging from 10 to 1000 mg/kg. These doses cover two to three orders of magnitude in concentrations; similarly, the current study covered two orders of magnitude for the PAH mixture and PCB mixture, and less than two orders for TCDD. Although many genes responded to the toxicants in the Bartosiewicz et al. study (13, 2 , and 3 genes for CdCl 2 , B[a]P, and TCE respectively), none of them responded over the entire range tested. The number of genes that responded over a tenfold dose range drops to 2, 2, and 0 for CdCl 2 , B[a]P, and TCE, respectively. Results showed a similar decrease in the numbers of genes that responded in a consistent manner across all doses, with 18 consistent genes for TCDD, 2 for PCBs, and 14 for PAHs. There was no overlap between the consistently responding genes for the three compounds/mixtures tested; gene ID, dose-related responses, and statistical data can be found in Appendix B. The existence of these unique genes whose expression is consistently affected by exposure to contaminants provides support for the hypothesis that gene expression can be used to detect and identify chemical classes of contaminants by their MOAs as evidenced by gene expression in environmental samples.
CONCLUSIONS AND FUTURE DIRECTIONS:
Gene expression profiles for the tested contaminants and contaminant mixtures appear to be characteristic of the test compounds and consistent over a large dose range, and thus may be useful for toxicant identification in field samples. However, confirmation of the gene responses via a secondary methodology such as RT-PCR is necessary. Additionally, in order to make this approach useful in simultaneously detecting multiple contaminants in environmental samples, testing chemical mixtures with mixed MOAs (e.g. combined exposure to PAHs and TCDD) is needed to determine whether the fingerprints are additive, and whether interactions between the contaminant classes alter the contaminant-specific responses observed and reported herein.
The number of potentially unique, dose-responsive genes is small enough to allow for the generation of a smaller customized array, or development of more rapid/less expensive methods for quantifying them (RT-PCR, glass arrays, etc.). If the expression fingerprints remain intact in exposures to the more complex mixtures found in environmental samples, it may be possible to rapidly assess the presence of multiple contaminants in a single assay (presence of unique expression fingerprint), as well as to assess the severity of the contamination (intensity of alterations in gene expression). 
POINTS OF CONTACT:

APPENDIX A CELL EXPOSURES:
Human hepatoma HepG2 cells were counted and checked for viability with Trypan Blue dye using a hemacytometer and microscope. Cells with >95 percent viability or better were then seeded at ~5 x 10 6 per T-150 flask (150 cm 2 growing surface area) and allowed to grow for several days until the cells reached ~80 percent confluency. Replicate flasks were then dosed with isooctane (solvent control) at 1 percent v/v or with the following compounds at different concentrations as shown in the table below. After 16 hr of exposure to the compounds of interest, cells from the same treatment were pooled, washed (with 1X phosphate buffered saline, PBS), counted, and centrifuged. The cell pellets were rinsed twice with PBS before proceeding with RNA isolation. Alternatively, the cell pellets were stored in 5 volumes of RNA Later (Ambion #7021) at -20oC for RNA isolation at a later and more convenient time without compromising RNA quality or yield.
RNA ISOLATION:
The following protocol was modified from BD Sciences/Clontech's Atlas™ Pure Total RNA Labeling Kit (User Manual PT3231-1, published 24 April, 2001) for the RNA isolation of cultured cells and subsequent DNase treatment of isolated RNA in microcentrifuge tubes. The procedure was optimized for the RNA isolation of 40 x 10 6 human hepatoma HepG2 cells, which yields ~100 µg RNA. Reagents in the protocol can be scaled up or down depending on the number of cells. 
RNA Isolation Materials needed
